The translational potential of the lung microbiome as a biomarker and a therapeutic target for chronic obstructive pulmonary disease
Abstract Chronic obstructive pulmonary disease (COPD) is a major chronic lung disease with a leading global morbidity and mortality. Emerging evidence suggests that the lung microbiome, the collection of the microorganisms in the lung, plays a crucial role in COPD pathogenesis. The lung microbiome a...
Main Authors: | Lei Yang, Naijian Li, Xinzhu Yi, Zhang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2023-10-01
|
Series: | Interdisciplinary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/INMD.20230023 |
Similar Items
-
The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease
by: Naijian Li, et al.
Published: (2023-07-01) -
The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer
by: Masamitsu Shimizu, et al.
Published: (2022-07-01) -
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
by: Betul Gok Yavuz, et al.
Published: (2023-10-01) -
Lung and Gut Microbiome in COPD
by: Efstathios Karakasidis, et al.
Published: (2023-05-01) -
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease
by: Naijian Li, et al.
Published: (2021-10-01)